Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Jagsonpal Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:507789NSE Symbol: JAGSNPHARMP/E(TTM):65.26
ISIN Demat:INE048B01027Div & Yield %:0.76EPS(TTM):10.08
Book Value(Rs):74.2613814Market Cap ( Cr.):1746.19Face Value(Rs):5
    Change Company 
( In Cr)
 Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
INCOME :      
Sales Turnover 208.70236.71217.58187.95158.57166.83
Excise Duty0.000.000.000.000.000.00
Net Sales208.70236.71217.58187.95158.57166.83
Other Income 9.285.733.434.392.531.43
Stock Adjustments -3.90-4.30-5.61-5.28-1.25-19.42
Total Income214.08238.14215.40187.06159.85148.84
EXPENDITURE :      
Raw Materials 76.0888.0483.3575.5054.9453.43
Power & Fuel Cost0.170.290.470.520.641.41
Employee Cost 61.8065.1857.6853.9850.3746.61
Other Manufacturing Expenses 0.730.520.910.480.450.73
Selling and Administration Expenses 41.0941.6642.5031.8838.3432.23
Miscellaneous Expenses 1.876.032.051.224.043.66
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure181.74201.72186.95163.59148.79138.07
Operating Profit32.3436.4228.4623.4711.0510.77
Interest 0.810.410.290.510.510.75
Gross Profit31.5336.0128.1722.9610.5410.02
Depreciation1.661.211.531.091.131.02
Profit Before Tax29.8734.8026.6421.879.419.00
Tax7.567.637.406.051.571.85
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-0.150.460.38-1.23-0.03-0.07
Reported Net Profit22.4626.7218.8617.067.877.22
Extraordinary Items 0.00-1.890.500.00-0.020.00
Adjusted Net Profit22.4628.6118.3617.067.897.22
Adjst. below Net Profit 0.29-1.563.95-3.540.000.00
P & L Balance brought forward94.5469.3758.5947.6941.1334.71
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 13.100.0012.022.621.310.79
P & L Balance carried down104.1994.5469.3758.5947.6941.13
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %100.00100.0080.0020.0010.005.00
Earnings Per Share-Unit Curr8.5010.207.206.513.002.75
Earnings Per Share(Adj)-Unit Curr8.5010.207.206.513.002.75
Book Value-Unit Curr70.8860.6550.6843.5539.3936.89